drug
ergotamine
Marketedupdated 3mo agoby Pangea Bio
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ergotamine
- phase3A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine
- phase3A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
- phase3A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that